Journal
SCIENCE TRANSLATIONAL MEDICINE
Volume 7, Issue 280, Pages -Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/scitranslmed.3010274
Keywords
-
Categories
Funding
- Ludwig Collaborative Laboratory
- Swim Across America
- American Cancer Society [MRSG-11-054-01-LIB]
- Cycle for Survival
Ask authors/readers for more resources
The recent approvals of two drugs that block the function of the immune checkpoint programmed cell death 1 (PD-1) have firmly planted tumor immunotherapy in the mainstream of clinical oncology. We provide a historical and immunologic context for these recent advances and discuss translational studies that provide insight into the efficacy of cancer immunotherapy at the individual patient level.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available